Stock Groups

U.S. administers 451.5 million doses of COVID-19 vaccines

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – Ione Thompson (10 years old) receives her first dose of Pfizer BioNTech’s coronavirus (COVID-19 vaccine) from Iman Yunis, Othello Station Pharmacy. This was done during the Seattle Public Schools school-day clinic at Bailey Gatzert elementary in Seattle, W

(Reuters) – The United States has administered 451,453,834 COVID-19 doses to the nation as of Sunday morning and distributed 566.964,025 doses.

These numbers are higher than the 449 955,588 doses that the CDC reported had been administered by Nov. 20.

According to the agency, 230,298,744 individuals had had at least one dose and 196,284,442 had had their entire vaccinations as of 6:06 a.m. ET Sunday

Two-dose vaccinations are included in the CDC tally Moderna (NASDAQ:) and Pfizer/BioNTech as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

A booster dose has been administered to approximately 35.4 million individuals Pfizer (NYSE:), Moderna or Johnson & Johnson’s COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]